All Issue

2025 Vol.6, Issue 2 Preview Page

Review article

30 June 2025. pp. 83-87
Abstract
Sorry, not available.
Click the PDF button.
References
1

Mulhall JP et al., Evaluation and management of testosterone deficiency: AUA guideline, J Urol, 2018

10.1016/j.juro.2018.03.11529601923
2

EAU Guidelines on Sexual and Reproductive Health. In EAU Guidelines. Edn. presented at the EAU Annual Congress, Madrid 2025. ISBN 978-94-92671-29-5. (Available at EAU Guidelines on Sexual and Reproductive Health - Uroweb).

3

Feldman HA et al., Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study, J Clin Endocrinol Metab, 2002

10.1210/jc.87.2.589
4

Triaboschi TLN et al., Rethinking Low Testosterone in Older Men: Association With Obesity Rather Than Aging, Urology, 2025

10.1016/j.urology.2025.02.01039970961
5

Vigen R et al., Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels, JAMA, 2013

10.1001/jama.2013.28038624193080
6

Food and Drug Administration. FDA cautions about using testosterone products for low testosterone due to aging: requires labeling change to inform of possible increased risk of heart attack and stroke with use. FDA drug safety communication. 2018

7

Traish AM et al., Death by Testosterone? We Think Not! J Sex Med, 2014

10.1111/jsm.1246424589170
8

Shores MM et al., Testosterone treatment and mortality in men with low testosterone levels, J Clin Endocrinol Metab, 2012

10.1210/jc.2011-259122496507
9

Muraleedharan V et al., Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes, Eur J Endocrinol, 2013

10.1530/EJE-13-032123999642
10

Lincoff AM et al., Cardiovascular Safety of Testosterone-Replacement Therapy, N Engl J Med, 2023

11

Morgentaler A et al., Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth, Eur Urol, 2009

10.1016/j.eururo.2008.09.02418838208
12

Pencina KM et al., Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism, J Clin Endocrinol Metab, 2024

13

Watts NB et al., Osteoporosis in men: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, 2012

10.1210/jc.2011-304522675062
14

Goettemoeller T et al., Lack of bone mineral density testing in men with hypogonadism: a clinical conundrum, J Endocr Soc, 2022

10.1210/jendso/bvac12936111272PMC9469919
15

Shigehara K et al., Relationship between Testosterone and Sarcopenia in Older-Adult Men: A Narrative Review, J Clin Med, 2022

10.3390/jcm1120620236294523PMC9605266
16

Bhasin S et al., Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Hypogonadism: A Substudy of the TRAVERSE Randomized Clinical Trial, JAMA Intern Med, 2024

10.1001/jamainternmed.2023.786238315466PMC10845044
17

Corona C et al., The Role of testosterone treatment in patients with metabolic disorders, Expert Rev Clin Pharmacol, 2021

10.1080/17512433.2021.193854834085587
18

Wittert G et al., Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial Diabetes Endocrinol, 2021

10.1016/S2213-8587(20)30367-333338415
19

Snyder PJ et al., Effects of Testosterone Treatment in Older Men, N Engl J Med, 2016

Information
  • Publisher :The Association of Korean Urologists
  • Publisher(Ko) :대한비뇨의학과의사회
  • Journal Title :비뇨의학 Urology Digest
  • Volume : 6
  • No :2
  • Pages :83-87